Journal Editors’ Trial Registry Proposal Will Be Taken “Under Advisement,” PhRMA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pharmaceutical Research & Manufacturers of America "welcomes" an upcoming proposal from a group of journal editors that will call for registration of clinical trials as a prerequisite for publication
You may also be interested in...
Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.
Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.
PhRMA Clinical Trial Registry Will Be Launched Oct. 1
Clinicalstudyresults.org will include results of all controlled “hypothesis testing” clinical trials completed since October 2002 for PhRMA member companies’ marketed products. Postings will include a drug’s label, a bibliography of published studies, and summaries of unpublished studies.